Endocrine Abstracts

Introduction: Cinacalcet therapy remains the only alternative to elective parathyroidectomy (EP) for lowering serum calcium (Ca) in patients with primary hyperparathyroidism (PHPT). National Institute of health and Care Excellence (NICE), UK support use of cinacalcet in symptomatic patients with PHPT who decline surgery (or deemed unfit for surgery), if serum Ca levels >2.85 mmol/l. The limitation in wider use of cinacalcet remains cost effectiveness apart from limited dat...